Pitfalls in the detection of disseminated non-hematological tumor cells

Annals of Oncology

Volumn 11, Issue 7, 2000, Pages 785-792

  Goeminne, J C ^a   Guillaume, T ^a   Symann, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Immunocytochemistry; RT PCR; Tumor cell detection

Indexed keywords

CANCER CELL; CANCER DIAGNOSIS; HUMAN; IMMUNOCYTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0033816147     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008398228018     Document Type: Review

References (95)

1. Detection and clinical importance of micrometastatic disease
2. Clinical relevance of minimal residual cancer in patients with solid malignancies
3. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
4. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors
5. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
6. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous-cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis
7. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
8. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
9. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
10. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
11. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis
12. Prognostic significance of bone marrow micrometastases in patients with gastric cancer
13. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
14. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
15. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival
16. The significance of hematogenous tumor-cell clumps in the metastatic process
17. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery
18. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients
19. Induction of tumour cell shedding into effluent venous blood breast cancer surgery
20. A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis
21. Detection of genomically-tagged cancer cells in different tissues at different stages of tumor development: Lack of correlation with the formation of metastasis
22. Tumor cells with organ-specific metastatic ability show distinctive trafficking in vivo: Analyses by positron emission tomography and bioimaging
23. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts
24. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
25. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells
26. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
27. Frequency of downregulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells
28. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
29. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
30. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction
31. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction
32. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
33. Positive immunostaining with MLuCl of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer
34. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
35. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients
36. Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
37. Immunodetection of small-cell lung cancer metastases in bone marrow using three monoclonal antibodies
38. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions
39. In situ hybridization of prostate-specific antigen mRNA in human prostate
40. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
41. Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin
42. Mucin genes are regulated by estrogen and dexamethasone
43. Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates
44. Evaluation of cytocentrifuge apparatus with special reference to the cellular recovery rate
45. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high-dose chemotherapy with autologous stem-cell support
46. Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer
47. Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells
48. Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms
49. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study
50. Keratin-positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. A possible pitfall in the immunocytochemical diagnosis of metastatic carcinoma
51. Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
52. Isolation of prostate-derived single cells and cell clusters from human peripheral blood
53. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small-cell lung carcinomas?
54. Benign lymph node inclusions mimicking metastatic carcinoma
55. Detection of microscopic melanoma metastases in sentinel lymph nodes
56. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood
57. Detection of immunocytochemically stained rare events using image analysis
58. Solid phase cytometry for detection of rare events
59. Molecular detection of genetic alterations in the serum of colorectal cancer patients
60. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients
61. Predictive value of genetic diagnosis for cancer micrometastasis: Histologic and experimental appraisal
62. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
63. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer
64. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
65. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases
66. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: Implications for the detection of hematogenous prostate cells and standardization
67. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors
68. The expression of prostate-specific membrane antigen in peripheral blood leukocytes
69. MUC1 expression in hematopoietic tissues
70. Avoiding false positives with PCR
71. Illegitimate transcription: Transcription of any gene in any cell type
72. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: Studies on the epithelial glycoprotein gene EGP-2
73. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction
74. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
75. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines
76. Quantification of tyrosinase, TRP-1, and TRP-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR-regulation by steroid hormones
77. Diagnosis of micrometastases by the amplification of tissue-specific genes
78. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
79. Glycoproteins of the carcinoembryonic antigen (CEA) family are expressed in sweat and sebaceous glands of human fetal and adult skin
80. Tyrosinase gene expression in human tissues
81. Identification of circulating tumour cells by RT-PCR in patients with colorectal cancer: Detection prior to evidence of metastasis
82. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy
83. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer
84. Detection of tumor messenger RNA in the serum of patients with malignant melanoma
85. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
86. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: A quality-assurance initiative of the EORTC Melanoma Cooperative Group
87. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction
88. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
89. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer
90. Developments in quantitative PCR
91. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers
92. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression
93. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes
94. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9
95. Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells